関連する実験動画
Updated: Sep 9, 2025
08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.0K
リファンピシン耐性結核の高齢患者における治療結果と関連する影響因子:中国における多センター,遡及的なコホート研究
Huicong Liu1, Liping Zou2, JiaJia Yu3
1Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
BMC infectious diseases
|September 1, 2025
まとめ
中国のリファンピシン耐性結核 (RR-TB) の高齢患者では,治療の成功率は低い. 低BMI,高度な薬剤耐性,および治療前の貧血は,この脆弱な集団における不利な結果の主要な予測因子でした.
科学分野:
- 公衆衛生
- 感染症
- ゲロントロジー
背景:
- リファンピシン耐性結核 (RR-TB) は,特に高齢者に影響を及ぼす世界的な健康問題です.
- 高齢者はRR-TBによって不釣り合いな影響を受け,独特の生物学的,治療的,社会的要因により感染に寄与します.
- 高齢者におけるRR-TBの管理は,世界的な結核対策に重大な障害をもたらします.
研究 の 目的:
- 中国でRR- TBと診断された高齢者の治療結果を評価する.
- この集団における不良治療結果に関連する独立した予測要因を特定する.
- 高齢者におけるRR-TB管理を改善するための標的型介入の情報提供
主な方法:
- 中国で248人の高齢RR-TB患者を含む多センターの遡及コホート研究 (2018年5月 - 2020年4月).
- 多変数ロジスティック回帰と傾向スコアマッチング (PSM) を使用して,不利な結果に関連する要因を分析した.
- SPSSを用いた統計分析
主要な成果:
- 治療の成功率は高齢のRR- TB患者の65. 7%で,不良の結果は34. 3%であった (失敗,死亡,フォローアップの喪失,評価の欠如).
- 副作用は56. 0%で発生し,貧血が最も一般的であった (25. 8%). ベダキリンとラインゾリドの使用はQT延長と光神経炎と相関しています.
- 不良結果の独立予測因子には,低BMI (<18. 5kg/ m2),高度な薬剤耐性,および治療前の貧血が含まれていた. 補助免疫療法は好ましい結果と関連していました.
結論:
- 中国の高等医院では,高齢のRR- TB患者の治療成功率は比較的低かった.
- 低BMI,高度な薬剤耐性,および治療前の貧血は,不利な結果のための重要な予後要因です.
- 補助免疫療法は前兆に良い効果を示した. 高齢の患者は,結核管理戦略において特別な配慮を必要とします.
さらに関連する動画
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.9K
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
8.7K
関連する概念動画
01:28Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
01:29Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
01:26Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
01:31Pulmonary Tuberculosis III
439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
439
01:28Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
01:28Pneumonia IV: Management
445
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
445